MAIA Stock Analysis: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.32
-0.04 (-2.94%)
▼
5d:
+1.54%
30d:
+4.76%
90d:
-12.0%
BUY
MODERATE Confidence
Analysis Updated: Jun 16, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MAIA shows positive signals but monitor for confirmation. Market pricing in 23.6% growth. Moderate conviction.
💡 BUY OPPORTUNITY: MAIA shows positive signals but monitor for confirmation. Market pricing in 23.6% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.94
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.58
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.32, which is considered slightly high relative to its 30-day fair value range of $1.26 to $1.37. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.2) compared to its historical average (0.6). At these levels, the market is pricing in 23.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.26, while resistance sits at $1.56.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.13 (+792.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.26, while resistance sits at $1.56.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.13 (+792.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.26 -
$1.37
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 792.3% below Wall St target ($12.13)
- BEARISH: Market expects 23.6% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$1.26 -
$1.37
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.26
Resistance Level
$1.56
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.21
Wall Street Target
$12.14
(+792.3%)
Valuation Premium vs History
+23.6% premium
PE vs Historical
1.2 vs 0.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+23.6%
(market-implied from PE analysis)
1-Year Target
$1.68
(+24%)
2-Year Target
$2.08
(+53%)
3-Year Target
$2.57
(+89%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
PE COMPRESSION
$1.27
(-7%)
Significant PE compression expected
Share & Embed Analysis
Last updated: June 16, 2026 4:15 PM ET
Data refreshes hourly during market hours. Next update: 5:15 PM
Data refreshes hourly during market hours. Next update: 5:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 59 HOLD |
